Literature DB >> 4835986

Central dopamine turnover in schizophrenic syndromes.

M B Bowers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4835986     DOI: 10.1001/archpsyc.1974.01760130034005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  20 in total

1.  Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.

Authors:  M B Bowers; R E Study
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

Review 2.  N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

Authors:  Joshua T Kantrowitz; Daniel C Javitt
Journal:  Brain Res Bull       Date:  2010-04-24       Impact factor: 4.077

3.  Some indices of the catecholamine and indoleamine metabolism in groups of patients with paranoid and simple forms of schizophrenia.

Authors:  N B Gamaleya
Journal:  Neurosci Behav Physiol       Date:  1985 Mar-Apr

4.  Schizophrenia: a theory.

Authors:  E Hartmann
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

5.  The effect of L-dopa and propranolol on human CSF cyclic nucleotides.

Authors:  R H Belmaker; R P Ebstein; J Biederman; R Stern; M Berman; H M van Praag
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

6.  Dopamine agonists for negative symptoms in schizophrenia.

Authors:  D J King
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

Review 7.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

8.  Plasma prolactin levels before and during propranolol treatment in chronic schizophrenia.

Authors:  J D Wilson; D J King; B Sheridan
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

9.  Dopamine receptor alteration in schizophrenia: neuroendocrine evidence.

Authors:  J Rotrosen; B M Angrist; S Gershon; E J Sachar; F S Halpern
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

10.  3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors.

Authors:  A J Cross; T J Crow; F Owen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.